A New Peptide from the Venom of the Madagascar Cat-Eyed Snake  Madagascarophis colubrinus  Blocks Nicotinic Acetylcholine Receptor

E. V. Kryukova; Крюкова Е. В.; D. A. Ivanov; Иванов Д. А.; N. V. Kopylova; Копылова Н. В.; V. G. Starkov; Старков В. Г.; T. V. Andreeva; Андреева Т. В.; I. A. Ivanov; Иванов И. А.; V. I. Tsetlin; Цетлин В. И.; Yu. N. Utkin; Уткин Ю. Н.

doi:10.31857/S0132342323030156

A New Peptide from the Venom of the Madagascar Cat-Eyed Snake Madagascarophis colubrinus Blocks Nicotinic Acetylcholine Receptor

Authors: Kryukova E.V.¹, Ivanov D.A.², Kopylova N.V.¹, Starkov V.G.¹, Andreeva T.V.¹, Ivanov I.A.¹, Tsetlin V.I.¹, Utkin Y.N.¹
Affiliations:
1. Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences
2. FKOO “Labkorp”
Issue: Vol 49, No 3 (2023)
Pages: 296-305
Section: Articles
URL: https://journals.rcsi.science/0132-3423/article/view/139153
DOI: https://doi.org/10.31857/S0132342323030156
EDN: https://elibrary.ru/PDSQUE
ID: 139153

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

In screening the venoms of various snake species, we found that the venom of the Madagascar cat-eyed snake Madagascarophis colubrinus competes with α-bungarotoxin for binding to the nicotinic acetylcholine receptor from Torpedo californica. Using liquid chromatography, a peptide, called macoluxin and inhibiting the binding of the toxin to the receptor, was isolated from the venom. The amino acid sequence of this 23-amino acid peptide was determined by automatic Edman degradation. Comparison with amino acid sequences of known proteins showed that the macoluxin sequence is homologous to the α-helical region of the sequence of snake venom metalloproteinases. The peptide was synthesized by solid-phase peptide synthesis, and the study of its biological activity showed that it inhibits the binding of α-bungarotoxin to the Torpedo receptor with an IC₅₀ of 47 μM. Macoluxin also reversibly inhibited acetylcholine-induced currents in the muscle-type nicotinic acetylcholine receptor. This is the first data on the presence in the venom of rear fanged snakes of a peptide that can inhibit the nicotinic acetylcholine receptor.

Keywords

Madagascar cat-eyed snake, venom, nicotinic acetylcholine receptor, peptide, inhibitor, macoluxin

References

Madagascarophis colubrinus (Schlegel, 1837) // The Reptile Database, 2022. https://reptile-database.reptarium.cz/species?genus= Madagascarophis&species=colubrinus&search_param= %28%28genus%3D%27madagascarophis%27%29%29
Domergue C.A. // Bull. Mus. Natn. Hist. Nat., Paris. 1987. V. 9. P. 455–489.
Domergue C.A. // Bull. Acad. Malgache. 1962. V. 40. P. 97–98.
Dashevsky D., Debono J., Rokyta D., Nouwens A., Josh P., Fry B.G. // J. Mol. Evol. 2018. V. 86. P. 531–545. https://doi.org/10.1007/s00239-018-9864-6
Heyborne W.H., Mackessy S.P. // Biochimie. 2013. V. 95. P. 1923–1932. https://doi.org/10.1016/j.biochi.2013.06.025
Calvete J.J., Bonilla F., Granados-Martínez S., Sanz L., Lomonte B., Sasa M. // J. Proteomics. 2020. V. 225. P. 103 882. https://doi.org/10.1016/j.jprot.2020.103882
Xie B., Dashevsky D., Rokyta D., Ghezellou P., Fathinia B., Shi Q., Richardson M.K., Fry B.G. // BMC Biol. 2022. V. 20. P. 4. https://doi.org/10.1186/s12915-021-01208-9
Koua D., Ebou A., Habbouche Z., Ballouard J.M., Caron S., Bonnet X., Dutertre S. // Toxicon X. 2022. V. 15. P. 100 130. https://doi.org/10.1016/j.toxcx.2022.100130
Vulfius C.A., Kasheverov I.E., Starkov V.G., Osipov A.V., Andreeva T.V., Filkin S.Y., Gorbacheva E.V., Astashev M.E., Tsetlin V.I., Utkin Y.N. // PLoS One. 2014. V. 9. P. e115428. https://doi.org/10.1371/journal.pone.0115428
Vulfius C.A., Kasheverov I.E., Kryukova E.V., Spirova E.N., Shelukhina I.V., Starkov V.G., Andreeva T.V., Faure G., Zouridakis M., Tsetlin V.I., Utkin Y.N. // PLoS One. 2017. V. 12. P. e0186206. https://doi.org/10.1371/journal.pone.0186206
Utkin Y.N., Weise C., Kasheverov I.E., Andreeva T.V., Kryukova E.V., Zhmak M.N., Starkov V.G., Hoang N.A., Bertrand D., Ramerstorfer J., Sieghart W., Thompson A.J., Lummis S.C., Tsetlin V.I. // J. Biol. Chem. 2012. V. 287. P. 27079–27086. https://doi.org/10.1074/jbc.M112.363051
Vulfius C.A., Spirova E.N., Serebryakova M.V., Shelukhina I.V., Kudryavtsev D.S., Kryukova E.V., Starkov V.G., Kopylova N.V., Zhmak M.N., Ivanov I.A., Kudryashova K.S., Andreeva T.V., Tsetlin V.I., Utkin Y.N. // Toxicon. 2016. V. 121. P. 70–76. https://doi.org/10.1016/j.toxicon.2016.08.020
Kryukova E.V., Vulfius C.A., Ziganshin R.H., Andreeva T.V., Starkov V.G., Tsetlin V.I., Utkin Y.N. // J. Venom Res. 2020. V. 10. P. 23–29.
Dutertre S., Nicke A., Tsetlin V.I. // Neuropharmacology. 2017. V. 127. P. 196–223. https://doi.org/10.1016/j.neuropharm.2017.06.011
Kudryavtsev D.S., Shelukhina I.V., Son L.V., Ojomoko L.O., Kryukova E.V., Lyukmanova E.N., Zhmak M.N., Dolgikh D.A., Ivanov I.A., Kasheverov I.E., Starkov V.G., Ramerstorfer J., Sieghart W., Tsetlin V.I., Utkin Y.N. // J. Biol. Chem. 2015. V. 290. P. 22747–22758. https://doi.org/10.1074/jbc.M115.648824
Shelukhina I., Spirova E., Kudryavtsev D., Ojomoko L., Werner M., Methfessel C., Hollmann M., Tsetlin V. // PLoS One. 2017. V. 12. P. e0181936. https://doi.org/10.1371/journal.pone.0181936
Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. // Nucleic Acids Res. 1997. V. 25. P. 3389–3402. https://doi.org/10.1093/nar/25.17.3389
Guan H.H., Goh K.S., Davamani F., Wu P.L., Huang Y.W., Jeyakanthan J., Wu W.G., Chen C.J. // J. Struct. Biol. 2010. V. 169. P. 294–303. https://doi.org/10.1016/j.jsb.2009.11.009
Brust A., Sunagar K., Undheim E.A., Vetter I., Yang D.C., Casewell N.R., Jackson T.N., Koludarov I., Alewood P.F., Hodgson W.C., Lewis R.J., King G.F., Antunes A., Hendrikx I., Fry B.G. // Mol. Cell. Proteomics. 2013. V. 12. P. 651–663. https://doi.org/10.1074/mcp.M112.023135
Nicolau C.A., Carvalho P.C., Junqueira-de-Azevedo I.L., Teixeira-Ferreira A., Junqueira M., Perales J., Neves-Ferreira A.G., Valente R.H. // J. Proteomics. 2017. V. 151. P. 214–231. https://doi.org/10.1016/j.jprot.2016.06.029
Jin A.H., Cristofori-Armstrong B., Rash L.D., Román-González S.A., Espinosa R.A., Lewis R.J., Alewood P.F., Vetter I. // Biochem. Pharmacol. 2019. V. 164. P. 342–348. https://doi.org/10.1016/j.bcp.2019.04.025
Shelukhina I.V., Zhmak M.N., Lobanov A.V., Ivanov I.A., Garifulina A.I., Kravchenko I.N., Rasskazova E.A., Salmova M.A., Tukhovskaya E.A., Rykov V.A., Slashcheva G.A., Egorova N.S., Muzyka I.S., Tsetlin V.I., Utkin Y.N. // Toxins (Basel). 2018. V. 10. P. 34. https://doi.org/10.3390/toxins10010034
Lebedev D.S., Kryukova E.V., Ivanov I.A., Egorova N.S., Timofeev N.D., Spirova E.N., Tufanova E.Y., Siniavin A.E., Kudryavtsev D.S., Kasheverov I.E., Zouridakis M., Katsarava R., Zavradashvili N., Iagorshvili I., Tzartos S.J., Tsetlin V.I. // Mol. Pharmacol. 2019. V. 96. P. 664–673. https://doi.org/10.1124/mol.119.117713